Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.
Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP; National Cardiovascular Data Registry. Mehta SK, et al. Among authors: lindsey jb. Circ Cardiovasc Interv. 2009 Jun;2(3):222-9. doi: 10.1161/CIRCINTERVENTIONS.108.846741. Epub 2009 May 8. Circ Cardiovasc Interv. 2009. PMID: 20031719
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Lindsey JB, et al. JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82. doi: 10.1016/j.jcin.2009.09.002. JACC Cardiovasc Interv. 2009. PMID: 19926047 Free article.
Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.
Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Lindsey JB, et al. Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80. doi: 10.1161/CIRCINTERVENTIONS.111.962233. Epub 2011 Oct 4. Circ Cardiovasc Interv. 2011. PMID: 21972402 Clinical Trial.
Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP; NCDR (National Cardiovascular Data Registry). Frutkin AD, et al. Among authors: lindsey jb. JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001. JACC Cardiovasc Interv. 2009. PMID: 19628183 Free article.
Incomplete stent apposition: should we appose or oppose?
Lindsey JB, Marso SP. Lindsey JB, et al. JACC Cardiovasc Interv. 2010 May;3(5):495-7. doi: 10.1016/j.jcin.2010.03.005. JACC Cardiovasc Interv. 2010. PMID: 20488405 Free article. No abstract available.
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.
Venkitachalam L, Lei Y, Stolker JM, Mahoney EM, Amin AP, Lindsey JB, Kennedy KF, Pencina MJ, Lopez JJ, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Venkitachalam L, et al. Among authors: lindsey jb. Circulation. 2011 Aug 30;124(9):1028-37. doi: 10.1161/CIRCULATIONAHA.110.978593. Epub 2011 Aug 15. Circulation. 2011. PMID: 21844081
34 results